Literature DB >> 26912763

Burkholderia ginsengisoli bacteraemia: emergence of a novel pathogen.

Laura R Marks1, Hema Dodd1, Thomas A Russo1, Charles S Berenson1.   

Abstract

Burkholderia ginsengisoli is a non-pathogenic Gram-negative bacterium that ordinarily serves as a plant endosymbiont. We report the first case of human infection with B. ginsengisoli presenting as bacteraemia in a young man with severe Crohn's disease. Definitive identification of the pathogen could not be accomplished with conventional techniques and required DNA sequencing. The bacteraemia may have been related to ingestion of organic vegetables and compromised gastrointestinal mucosa, coupled with treatment with tumour necrosis factor α inhibitors. Although there are no standard antibiotics to treat this pathogen, we devised a successful treatment regimen. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912763      PMCID: PMC4769455          DOI: 10.1136/bcr-2015-213584

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Endophytic colonization of Vitis vinifera L. by plant growth-promoting bacterium Burkholderia sp. strain PsJN.

Authors:  Stéphane Compant; Birgit Reiter; Angela Sessitsch; Jerzy Nowak; Christophe Clément; Essaïd Ait Barka
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

2.  Infections in patients with rheumatoid arthritis treated with biologic agents.

Authors:  Joachim Listing; Anja Strangfeld; Sonja Kary; Rolf Rau; Ulrich von Hinueber; Maria Stoyanova-Scholz; Erika Gromnica-Ihle; Christian Antoni; Peter Herzer; Jörn Kekow; Matthias Schneider; Angela Zink
Journal:  Arthritis Rheum       Date:  2005-11

Review 3.  Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance.

Authors:  Fabrizio Cantini; Laura Niccoli; Delia Goletti
Journal:  J Rheumatol Suppl       Date:  2014-05

Review 4.  Common features of environmental and potentially beneficial plant-associated Burkholderia.

Authors:  Zulma Rocío Suárez-Moreno; Jesús Caballero-Mellado; Bruna G Coutinho; Lucia Mendonça-Previato; Euan K James; Vittorio Venturi
Journal:  Microb Ecol       Date:  2011-08-18       Impact factor: 4.552

Review 5.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

6.  Burkholderia ginsengisoli sp. nov., a beta-glucosidase-producing bacterium isolated from soil of a ginseng field.

Authors:  Ho-Bin Kim; Min-Ju Park; Hee-Chan Yang; Dong-Shan An; Hai-Zhu Jin; Deok-Chun Yang
Journal:  Int J Syst Evol Microbiol       Date:  2006-11       Impact factor: 2.747

Review 7.  Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.

Authors:  Daniel Tracey; Lars Klareskog; Eric H Sasso; Jochen G Salfeld; Paul P Tak
Journal:  Pharmacol Ther       Date:  2007-10-26       Impact factor: 12.310

8.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

9.  Increased risk of bacterial endocarditis in inflammatory bowel disease.

Authors:  G Kreuzpaintner; D Horstkotte; A Heyll; B Lösse; G Strohmeyer
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

10.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Authors:  Jean-Frederic Colombel; Edward V Loftus; William J Tremaine; Laurence J Egan; W Scott Harmsen; Cathy D Schleck; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  2 in total

1.  Class III Histidine Kinases: a Recently Accessorized Kinase Domain in Putative Modulators of Type IV Pilus-Based Motility.

Authors:  Ogun Adebali; Marharyta G Petukh; Alexander O Reznik; Artem V Tishkov; Amit A Upadhyay; Igor B Zhulin
Journal:  J Bacteriol       Date:  2017-08-22       Impact factor: 3.490

2.  Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans.

Authors:  Scott A Becka; Elise T Zeiser; Steven H Marshall; Julian A Gatta; Kevin Nguyen; Indresh Singh; Chris Greco; Granger G Sutton; Derrick E Fouts; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-18       Impact factor: 2.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.